Skip to main content

Table 2 Differences in the transcription level of the OTUD family in pancreatic cancer and normal pancreatic tissues (TCGA and GTEx)

From: YOD1 serves as a potential prognostic biomarker for pancreatic cancer

Gene ConMean TreatMean Log2FC P-Value FDR
OTUD1* 2.34 4.82 2.47 1.06E−52 6.36E−52
YOD1* 1.20 2.56 1.35 2.20E−50 8.75E−50
OTUD3 1.95 1.61 − 0.33 7.10E−14 9.13E−14
OTUD4 \ \ \ \ \
OTUD5* 9.94 13.71 3.76 1.53E−45 4.15E−45
OTUD6A \ \ \ \ \
OTUD6B 1.77 2.19 0.41 1.17E−08 1.39E−08
ALG13 7.57 2.89 − 4.68 4.72E−53 3.16E−52